Express Scripts said on Monday that it would buy the pharmacy benefits management business of WellPoint for $4.68bn, in a deal that will make Express Scripts the second-largest US drug benefits manager in terms of prescriptions processed. Express Scripts will pay $3.28bn in cash, with the rest to be paid in stock, to WellPoint, a top US health insurer that provides benefits under the Blue Cross Blue Shield brand.

This entry was posted by Gwen Robinson on Tuesday, April 14th, 2009 at 4:12 and is filed under Capital markets, M&A. Tagged with express scripts, WellPoint. Edit this entry.